We are live on ! Find out more
BIM

Bogle Investment Management Portfolio holdings

AUM $63M
1-Year Est. Return 51.97%
This Fund
S&P 500
This Quarter Est. Return
+35.49%
1 Year Est. Return
+51.97%
3 Year Est. Return
+181.13%
5 Year Est. Return
+959%
10 Year Est. Return
AUM
$1.39B
AUM Growth
-$56.3M
Cap. Flow
-$222M
Cap. Flow %
-16.04%
Top 10 Hldgs %
12.35%
Holding
543
New
167
Increased
70
Reduced
102
Closed
198

Sector Composition

Rank Sector Weight
1 Healthcare 22.43%
2 Technology 17.94%
3 Consumer Discretionary 12.59%
4 Industrials 10.51%
5 Materials 8.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TFSL icon
301
TFS Financial
TFSL
$5.22B
$499K 0.04%
+28,031
New +$504K
EXAR
302
DELISTED
Exar Corporation
EXAR
$490K 0.04%
+52,693
New +$460K
COTV
303
DELISTED
Cotiviti Holdings, Inc.
COTV
$481K 0.03%
+14,346
New +$403K
LYV icon
304
Live Nation Entertainment
LYV
$42.8B
$475K 0.03%
+17,290
New +$451K
TECH icon
305
Bio-Techne
TECH
$11.2B
$462K 0.03%
16,888
-240,448
-93% -$6.6M
FMBI
306
DELISTED
First Midwest Bancorp Inc/IL
FMBI
$448K 0.03%
23,190
-3,487
-13% -$65.9K
YELL
307
DELISTED
Yellow Corporation Common Stock
YELL
$439K 0.03%
35,697
-347,497
-91% -$3.88M
GGB icon
308
Gerdau
GGB
$10B
$428K 0.03%
198,527
-118,566
-37% -$238K
SHOE
309
Shoe Station Group
SHOE
$422M
$427K 0.03%
+32,042
New +$431K
ARAY icon
310
Accuray
ARAY
$37.2M
$424K 0.03%
66,577
-262,899
-80% -$1.43M
INFN
311
DELISTED
Infinera Corporation Common Stock
INFN
$424K 0.03%
47,000
+1,504
+3% +$14.5K
BBG
312
DELISTED
Bill Barrett Corp
BBG
$419K 0.03%
75,369
-10,124
-12% -$60.2K
ADVM
313
DELISTED
Adverum Biotechnologies
ADVM
$404K 0.03%
9,838
-4,814
-33% -$183K
ELOS
314
DELISTED
Syneron Medical Ltd
ELOS
$392K 0.03%
54,789
+8,797
+19% +$61.2K
MGI
315
DELISTED
MoneyGram International, Inc. New
MGI
$384K 0.03%
54,191
-28,357
-34% -$202K
MCRB icon
316
Seres Therapeutics
MCRB
$50.8M
$369K 0.03%
+1,505
New +$528K
SUP
317
DELISTED
Superior Industries International
SUP
$369K 0.03%
12,686
-87,600
-87% -$2.54M
ENTA icon
318
Enanta Pharmaceuticals
ENTA
$387M
$368K 0.03%
+13,832
New +$321K
HDSN
319
Hudson Technologies
HDSN
$266M
$362K 0.03%
+54,585
New +$288K
FHN icon
320
First Horizon
FHN
$12.4B
$355K 0.03%
+23,325
New +$345K
FBC
321
DELISTED
Flagstar Bancorp, Inc. New
FBC
$352K 0.03%
+12,691
New +$343K
NVTR
322
DELISTED
Nuvectra Corporation Common Stock
NVTR
$301K 0.02%
43,507
-23,806
-35% -$164K
JBSS icon
323
John B. Sanfilippo & Son
JBSS
$986M
$293K 0.02%
5,720
-65,180
-92% -$3.13M
REX icon
324
REX American Resources
REX
$1.46B
$285K 0.02%
+20,178
New +$246K
PRTK
325
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$285K 0.02%
+21,937
New +$291K

Similar funds

Bogle Investment Management's Q3 2016 Portfolio in Review

As of Q3 2016, Bogle Investment Management held 543 positions worth $1.39B, down 3.9% from $1.44B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Bogle Investment Management withdrew a net $222M in Q3 2016, closing 198 positions and reducing 102 holdings. Its most notable exit was NRG Energy, an estimated $20M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 21% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Bogle Investment Management opened a new position in Myriad Genetics worth $10.9M.

  • Bogle Investment Management's largest Q3 2016 buy was Myriad Genetics: 528,969 shares worth $10.9M.
  • Bogle Investment Management added most to The Meet Group, Inc. Common Stock in Q3 2016, an estimated $7.93M increase.
  • Bogle Investment Management's biggest Q3 2016 reduction was VWR Corporation, cutting an estimated $11.9M.
  • Bogle Investment Management fully exited NRG Energy in Q3 2016, selling an estimated $20M.
  • Bogle Investment Management's ten largest holdings make up 12% of its $1.39B portfolio in Q3 2016.
  • Bogle Investment Management opened 167 new positions and closed 198 in Q3 2016.
  • Bogle Investment Management's portfolio value fell 3.9% quarter-over-quarter to $1.39B.

Based on Bogle Investment Management's 13F filing for Q3 2016, filed 14 Nov 2016.